Mimosa Therapeutics, A Public Benefit Corp

Businessfiled

Mimosa Therapeutics, A Public Benefit Corp operates in Pharma, based in ALAMEDA.

Sub-sector tags: pharma.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Mimosa Therapeutics, A Public Benefit Corp has raised $1.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $865K on 2021-02-09.

Most recent recorded round closed around 2021-07-01.

Valuation (modeled)modeled

Provath models Mimosa Therapeutics, A Public Benefit Corp at approximately $11M (range $224K–$88M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.78× the median modeled value of Pre-Seed Pharma companies in 2019–2021 (20 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 5.0 yr ago; this sector typically re-raises about every 16 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 38% of Pharma peers (310 compared).

Modeled value ranks above 35% of those peers.

Closest niche peers: Jupiter Therapeutics, Inc., Tavros Therapeutics, Inc., Kalytera Therapeutics, Inc., Veterinary Radiation Oncology of the Chesapeake, LLC, Chamishi Therapeutics, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.